Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001519749-22-000004
Filing Date
2022-03-01
Accepted
2022-03-01 16:55:02
Documents
1
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 11780
  Complete submission text file 0001519749-22-000004.txt   13093
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Hart Jayne B. (Reporting) CIK: 0001519749 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 22699212